A first-of-its-kind study will investigate the use of MDMA-assisted psychotherapy for the treatment of female Hypoactive Sexual Desire Disorder (HSDD).
Heroic Hearts UK research director Grace Blest-Hopley discusses the organisation’s groundbreaking study that will investigate the use of psilocybin for treating brain trauma in veterans.
Heroic Hearts UK CEO Keith Abraham discusses his journey to setting up the organisation which aims to help veterans living with PTSD.
Mind Medicine has presented its novel findings on LSD and psilocybin from several ongoing studies.
An Italian cannabis referendum could potentially lead to the decriminalisation of psychotropic substance cultivation, such as cannabis and mushrooms, for personal use if successful.
The successful completion of Phase I of the world’s first clinical trial investigating the use of DMT-assisted therapy could lay the foundation for a “new paradigm”...
Psychiatrist Dr Tiago Reis Marques discusses what new research findings on ketamine mean for treatment-resistant mental conditions such as major depressive disorder.
Mind Cure Health has joined the Digital Therapeutics Alliance in a bid to drive awareness and adoption of digital therapies.
As the ecosystem around psychedelics in Europe develops, UK-based Clerkenwell Health is cementing itself as a serious player on the continent with the appointment of clinical...
The Multidisciplinary Association for Psychedelic Studies (MAPS) has received funding of $1.5m from Wasana Health in a first-of-its-kind collaboration to accelerate research into MDMA-assisted therapy for...
A new, pooled analysis has found that single-dose, clinical administration of LSD is safe in regards to acute psychological and physical harm in healthy subjects.
The first patient has received a dose of psilocybin in the world’s first trial investigating psilocybin as a treatment for a rare and debilitating headache disorder...